Name | Thalidomide-O-amido-PEG3-C2-NH2 hydrochloride |
---|---|
Synonyms | MFCD31656717 |
Description | Thalidomide-O-amido-PEG3-C2-NH2 hydrochloride is a synthesized E3 ligase ligand-linker conjugate that incorporates the Thalidomide based cereblon ligand and 3-unit PEG linker used in PROTAC technology[1]. |
---|---|
Related Catalog | |
Target |
Cereblon |
In Vitro | Thalidomide-O-amido-PEG3-C2-NH2 hydrochloride is composed of Degron (E3 ubiquitin ligase) and a linker, and they are used in PROTAC technology. Thalidomide-O-amido-PEG3-C2-NH2 binds to the targeting ligand to induce the target protein (including BRD4, BRD2, and BRD3) degradation[1]. |
References |
[1]. Methods to induce targeted protein degradation through bifunctional molecules. WO2017007612A1. |
Molecular Formula | C23H31ClN4O9 |
---|---|
Molecular Weight | 542.97 |
Storage condition | 2-8°C |